BDTX Black Diamond Therapeutics, Inc.

Fundamentals / CIK 0001701541 / USD

Black Diamond Therapeutics, Inc. reported $0 in revenue and a net loss of $44.07M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BDTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$82.25M$41.13M$0-$123.4MFY 2018 Revenue: $0FY 2018 Net Income: -$8.93M2018FY 2019 Revenue: $0FY 2019 Net Income: -$35.26M2019FY 2020 Revenue: $0FY 2020 Net Income: -$67.25M2020FY 2021 Net Income: -$125.6M2021FY 2022 Net Income: -$91.17M2022FY 2023 Net Income: -$82.44M2023FY 2024 Revenue: $0FY 2024 Net Income: -$69.68M2024FY 2025 Revenue: $70.00MFY 2025 Net Income: $22.37M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $70.00M $0 -- -- -- $0 $0 $0
Research & Development $33.56M $51.31M $59.35M $64.44M $96.83M $48.21M $21.75M $6.95M
Total Operating Expenses $57.48M $78.78M $86.46M $92.83M $126.9M $69.57M $29.33M $8.90M
Operating Income $12.52M -$78.78M -$86.46M -$92.83M -$126.9M -$69.57M -$29.33M -$8.90M
EBITDA $12.85M -$78.44M -$86.02M -$92.32M -$126.7M -$69.52M -$29.29M -$8.86M
Interest Expense -- -- -- -- $0 $1.0K $0 --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $22.37M -$69.68M -$82.44M -$91.17M -$125.6M -$67.25M -$35.26M -$8.93M
Basic EPS $0.39 -$1.27 -$1.88 -$2.52 -$3.47 -$2.05 -$16.99 -$1.47
Diluted EPS $0.39 -$1.27 -$1.88 -$2.52 -$3.47 -$2.05 -$16.99 -$1.47
Basic Shares Outstanding 56.9M 55.0M 44.0M 36.3M 36.2M 32.9M 2.1M 6.1M
Diluted Shares Outstanding 57.6M 55.0M 44.0M 36.3M 36.2M 32.9M 2.1M 6.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $70.00M $0
Research & Development $6.97M $7.39M $7.00M $6.30M $7.44M $9.32M $10.51M $12.30M
Total Operating Expenses $12.12M $12.06M $11.26M $17.61M $10.98M $13.42M $15.47M $18.27M
Operating Income -$12.12M -$12.06M -$11.26M -$17.61M -$10.98M -$13.42M $54.53M -$18.27M
EBITDA -$12.09M -$12.03M -$11.23M -$17.54M -$10.89M -$13.33M $54.62M -$18.19M
Income Tax Expense -- -- -- -- -- $0 $226K --
Net Income -$10.01M -$9.90M -$9.04M -$15.12M -$8.50M -$10.56M $56.54M -$15.98M
Basic EPS -$0.17 -$0.17 -$0.16 -- -$0.15 -$0.19 $1.00 --
Diluted EPS -$0.17 -$0.17 -$0.16 -- -$0.15 -$0.19 $0.98 --
Basic Shares Outstanding 57.5M 57.4M 57.2M -- 56.9M 56.8M 56.7M --
Diluted Shares Outstanding 57.5M 57.4M 57.2M -- 56.9M 56.8M 57.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $20.99M $36.44M $56.22M $34.31M $65.80M $34.60M $154.7M $51.66M
Short-Term Investments $107.7M $62.14M $75.18M $88.49M $144.0M $280.5M $0 --
Cash & Short-Term Investments $128.7M $98.58M $131.4M $122.8M $209.8M $315.1M $154.7M $51.66M
Total Current Assets $132.4M $101.2M $134.0M $127.7M $215.7M $319.6M $155.7M $51.68M
Property, Plant & Equipment, Net $365K $1.39M $1.73M $2.59M $3.04M $385K $164K $134K
Long-Term Investments -- -- -- -- -- -- $0 --
Other Non-Current Assets $73K $249K $0 $0 $16K $106K $59K $8.0K
Total Non-Current Assets $10.57M $21.46M $24.53M $28.55M $31.98M $10.12M $2.58M $142K
Total Assets $143.0M $122.6M $158.6M $156.3M $247.7M $329.7M $158.3M $51.83M
Accounts Payable $579K $4.01M $2.32M $1.88M $4.11M $2.54M $1.96M $416K
Total Current Liabilities $15.73M $20.57M $19.65M $15.26M $23.64M $14.22M $4.86M $2.58M
Total Non-Current Liabilities $15.07M $18.78M $22.18M $25.30M $28.14M $7.69M $16K $4.02M
Total Liabilities $30.80M $39.35M $41.83M $40.56M $51.78M $21.91M $4.88M $6.60M
Total Debt (incl. Leases) $18.78M $22.18M $25.30M $28.14M $29.47M $8.74M -- --
Common Stock $8.0K $7.0K $7.0K $5.0K $5.0K $5.0K $1.0K $1.0K
Retained Earnings -$464.7M -$487.1M -$417.4M -$335.0M -$243.8M -$118.2M -$50.97M -$15.71M
Accumulated Other Comp. Income $101K $24K -$27K -$1.82M -$414K $614K $0 --
Total Stockholders' Equity $112.2M $83.28M $116.7M $115.7M $195.9M $307.8M -$47.16M -$15.54M
Total Equity $112.2M $83.28M $116.7M $115.7M $195.9M $307.8M -$47.16M -$15.54M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $15.08M $19.19M $30.07M $20.99M $30.86M $29.99M $98.42M $36.44M
Short-Term Investments $86.95M $91.31M $88.19M $107.7M $104.6M $112.8M $53.98M $62.14M
Cash & Short-Term Investments $102.0M $110.5M $118.3M $128.7M $135.5M $142.8M $152.4M $98.58M
Total Current Assets $106.5M $115.4M $123.0M $132.4M $139.0M $146.7M $155.7M $101.2M
Property, Plant & Equipment, Net $282K $310K $338K $365K $1.13M $1.21M $1.30M $1.39M
Other Non-Current Assets $249K $285K $29K $73K $117K $161K $205K $249K
Total Non-Current Assets $9.02M $9.63M $9.96M $10.57M $18.74M $19.66M $20.57M $21.46M
Total Assets $115.6M $125.0M $132.9M $143.0M $157.7M $166.4M $176.2M $122.6M
Accounts Payable $1.04M $1.40M $2.97M $579K $975K $771K $2.63M $4.01M
Total Current Liabilities $15.40M $15.84M $14.53M $15.73M $15.54M $16.80M $16.85M $20.57M
Total Non-Current Liabilities $12.08M $13.10M $14.09M $15.07M $16.04M $16.97M $17.88M $18.78M
Total Liabilities $27.48M $28.94M $28.62M $30.80M $31.58M $33.77M $34.73M $39.35M
Total Debt (incl. Leases) $16.04M $16.97M $17.88M $18.78M $19.67M $20.75M $21.59M $22.18M
Common Stock $8.0K $8.0K $8.0K $8.0K $8.0K $7.0K $7.0K $7.0K
Retained Earnings -$493.7M -$483.7M -$473.8M -$464.7M -$449.6M -$441.1M -$430.6M -$487.1M
Accumulated Other Comp. Income -$309K -$68K -$36K $101K $142K -$25K -$19K $24K
Total Stockholders' Equity $88.08M $96.09M $104.3M $112.2M $126.2M $132.6M $141.5M $83.28M
Total Equity $88.08M $96.09M $104.3M $112.2M $126.2M $132.6M $141.5M $83.28M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $22.37M -$69.68M -$82.44M -$91.17M -$125.6M -$67.25M -$35.26M -$8.93M
Depreciation & Amortization $325K $343K $437K $508K $205K $52K $47K $44K
Stock-Based Compensation $6.63M $10.63M $9.60M $12.20M $14.04M $7.76M $3.64M $64K
Change in Payables -$3.43M $1.68M $597K -$2.23M $1.57M $1.07M $1.45M $264K
Operating Cash Flow $29.61M -$62.30M -$66.72M -$85.08M -$100.1M -$52.15M -$24.67M -$8.45M
Capital Expenditure -- $0 -$33K -$192K -$2.71M -$142K -$21K -$76K
Free Cash Flow -- -$62.30M -$66.75M -$85.27M -$102.9M -$52.29M -$24.70M -$8.53M
Purchases of Investments -$164.0M -$122.9M -$61.89M -$60.14M -$49.51M -$372.5M $0 --
Investing Cash Flow -$44.91M $16.97M $16.35M $53.37M $130.6M -$281.7M -$21K -$76K
Common Stock Issued $0 $24.49M $71.85M $0 -- -- -- --
Financing Cash Flow -$146K $25.55M $71.93M $177K $729K $214.9M $127.8M $52.31M
Net Change in Cash -$15.44M -$19.79M $21.56M -$31.54M $31.19M -$118.9M $103.1M $43.78M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$10.01M -$9.90M -$9.04M -$15.12M -$8.50M -$10.56M $56.54M -$15.98M
Depreciation & Amortization $28K $28K $27K $66K $86K $86K $87K $85K
Stock-Based Compensation $2.23M $1.51M $1.45M $1.41M $1.74M $1.78M $1.70M $1.64M
Change in Payables -$363K -$1.56M $2.39M -$396K $204K -$1.86M -$1.38M $2.04M
Operating Cash Flow -$8.34M -$7.97M -$10.23M -$6.79M -$7.85M -$9.16M $53.41M -$15.05M
Purchases of Investments -$22.28M -$18.12M $0 -$35.90M -$14.91M -$89.75M -$23.47M -$2.99M
Investing Cash Flow $4.22M -$3.12M $19.50M -$2.89M $8.59M -$59.15M $8.55M $27.77M
Common Stock Issued -- -- -- $0 $0 $0 $0 $0
Financing Cash Flow $12K $217K -$185K -$196K $134K -$116K $32K $291K
Net Change in Cash -$4.11M -$10.88M $9.08M -$9.87M $874K -$68.43M $61.99M $13.01M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 17.9% -- -- -- -- -- -- --
Net Profit Margin 32.0% -- -- -- -- -- -- --
Return on Equity (ROE) 19.9% -83.7% -70.6% -78.8% -64.1% -21.9% -- --
Return on Assets (ROA) 15.6% -56.8% -52.0% -58.3% -50.7% -20.4% -22.3% -17.2%
Current Ratio 8.42x 4.92x 6.82x 8.37x 9.12x 22.48x 32.02x 20.07x
Quick Ratio 8.18x 4.79x 6.69x 8.05x 8.87x 22.16x 31.80x 20.06x
Debt to Equity 0.17x 0.27x 0.22x 0.24x 0.15x 0.03x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- 17.9% 16.9% 6.7% -5.7% --
Net Profit Margin -- -- -- 32.0% 30.7% 20.6% 7.3% --
Return on Equity (ROE) -50.0% -44.3% -41.4% 19.9% 17.0% 10.9% 3.6% -83.7%
Return on Assets (ROA) -38.1% -34.0% -32.5% 15.6% 13.6% 8.7% 2.9% -56.8%
Current Ratio 6.92x 7.28x 8.46x 8.42x 8.94x 8.73x 9.24x 4.92x
Quick Ratio 6.62x 6.98x 8.14x 8.18x 8.72x 8.50x 9.05x 4.79x
Debt to Equity 0.18x 0.18x 0.17x 0.17x 0.16x 0.16x 0.15x 0.27x
Revenue Growth (YoY) -- -- -100.0% -- -- -- -- --
Operating Income Growth (YoY) -- -- -120.6% -- -- -- -- --
Net Income Growth (YoY) -- -- -116.0% -- -- -- -- --
EPS Growth (YoY) -- -- -116.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -119.2% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001701541) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal